Related references
Note: Only part of the references are listed.Clinical Evaluation of Targeted Arterial Infusion of Verapamil in the Interventional Chemotherapy of Primary Hepatocellular Carcinoma
Jin Huang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2011)
Recent Advances in the Development of P-gp Inhibitors
Christiane Baumert et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
Expression of multidrug resistance-related proteins p-glycoproteinglutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma
Hongcan Shi et al.
CANCER INVESTIGATION (2008)
Nonresectable hepatocellular carcinoma: Long-term toxicity in patients treated with transarterial chemoembolization - Single-center experience
Manon Buijs et al.
RADIOLOGY (2008)
Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma
Guang Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Comparison of therapeutic effectiveness of combined interventional therapy for 1126 cases of primary liver cancer
Ya-Min Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer
Joseph A. Ludwig et al.
CANCER RESEARCH (2006)
Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC)
A Veltri et al.
EUROPEAN RADIOLOGY (2006)
Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy
A Trotti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
